DODGE & COX – Alnylam Pharmaceuticals, Inc. Transaction History
DODGE & COX portfolio value:
$978.64M
portfolio value
DODGE & COX quarter portfolio value change:
+37.24%
quarter
Alnylam Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -7.03% | -369.65K shares | 211.62M | $200.16 | 4.88M |
| Q2 2022 | share | Decrease | -3.96% | -216.71K shares | -127.10M | $145.85 | 5.25M |
| Q1 2022 | share | Increase | +0.82% | 44.6K shares | -26.87M | $163.29 | 5.47M |
| Q4 2021 | share | Increase | +1.10% | 58.96K shares | -93.30M | $171.03 | 5.43M |
| Q3 2021 | share | Decrease | -0.77% | -41.90K shares | 96.52M | $188.81 | 5.37M |
| Q2 2021 | share | Increase | +25.28% | 1.09M shares | 307.61M | $169.52 | 5.41M |
| Q1 2021 | share | Decrease | -6.86% | -318.28K shares | 7.12M | $141.19 | 4.32M |
| Q4 2020 | share | Decrease | -0.81% | -37.7K shares | -78.01M | $129.97 | 4.63M |
| Q3 2020 | share | Decrease | -0.55% | -26.05K shares | -15.60M | $145.6 | 4.67M |
| Q2 2020 | share | Decrease | -7.65% | -389.67K shares | 142.25M | $148.11 | 4.70M |
| Q1 2020 | share | Decrease | -3.01% | -157.97K shares | -50.38M | $108.85 | 5.09M |
| Q4 2019 | share | Decrease | -1.14% | -60.48K shares | 177.62M | $115.17 | 5.25M |
| Q3 2019 | share | Increase | +1.34% | 70.3K shares | 46.85M | $80.42 | 5.31M |
| Q2 2019 | share | Increase | +4.87% | 243.5K shares | -86.74M | $72.56 | 5.24M |
| Q1 2019 | share | Increase | +6.56% | 307.75K shares | 125.09M | $93.45 | 4.99M |
| Q4 2018 | share | Increase | +0.74% | 34.6K shares | -65.49M | $72.91 | 4.69M |
| Q3 2018 | share | Increase | +0.02% | 950 shares | -50.97M | $87.52 | 4.65M |
| Q2 2018 | share | Decrease | -0.81% | -38.14K shares | -100.47M | $98.49 | 4.65M |
| Q1 2018 | share | Decrease | -42.99% | -3.53M shares | -486.90M | $119.1 | 4.69M |
| Q4 2017 | share | Decrease | -9.95% | -909.9K shares | -28.21M | $127.05 | 8.23M |
| Q3 2017 | share | Decrease | -0.48% | -44.32K shares | 341.37M | $117.49 | 9.14M |
| Q2 2017 | share | Decrease | -2.27% | -213.42K shares | 250.95M | $79.76 | 9.18M |
| Q1 2017 | share | Increase | +2.11% | 194.29K shares | 137.07M | $51.25 | 9.39M |
| Q4 2016 | share | Increase | +74.47% | 3.92M shares | -12.97M | $37.44 | 9.20M |
| Q3 2016 | share | Increase | +109.64% | 2.75M shares | 217.96M | $67.78 | 5.27M |
| Q2 2016 | share | Increase | 0.00% | 2.51M shares | 139.65M | $55.49 | 2.51M |